Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
Persistence Market Research’s report on the global atrophic scar treatment market in its first part throws light on the key factors impacting the performance of the market. Favorable regulatory standards, increasing healthcare expenditure, growing inclination towards high-quality personal care, soaring demand for age-defying treatment therapies, and increasing prevalence of dermatological ailments are only a few to mention.
Persistence Market Research utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. This methodology ensures high quality and accuracy of information. Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate, and treatment pattern, as per disease indications. Each piece of information is eventually analyzed during the entire research project which builds a strong base for the primary research information. Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of drugs, key treatment patterns, adoption rate, and compliance rate.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analyzed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level. On the other hand, we also analyze various companies’ annual reports, investor presentations, SEC filings, 10k reports and press releases operating in this market segment to fetch substantial reliable information about the market size, trends, opportunity, drivers, restraints, and in the end, to analyze key players, their operating strategies, and respective market shares. Key companies are segmented at tier level based on their revenues, product portfolio, and global market presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Standard Report Structure
Key Questions Answered
The global market for atrophic scar treatment has been classified on the basis of product type and end-user. The report analyses each segment and sub-segment to provide historical, current, and estimated scenario in the global atrophic scar treatment market during the assessment period.
Analyst’s Point of View
According to a research analyst involved in the study of the global market for atrophic scar treatment, the market has an overall positive outlook towards growth over the next few years. Several innovations are entering the industry and a majority of them are getting popularity within a short time. Persistence Market Research emphasized on end-user tracking in order to get the actual picture of the market. Adoption of different scar treatments or products by end-users has been central to the researchers. In addition, the report is also based on changing consumer preference for hospitals, specialty centers, clinics, and others. Frequent product innovation tends seems to introduce multiple alternatives to reduce treatment costs. “Among CO2 laser and pulsed dye laser, the former laser therapy has gained greater traction among consumers, as it is a less invasive, less painful, and relatively quicker procedure,” notes a research analyst, Persistence Market Research, Healthcare Pharmaceutical Drugs domain.
The US$ 4.65 Bn global atrophic scar treatment market is presumed to exhibit 1.3x growth by the end of 2025. Over the forecast period 2017-2025, the global market for atrophic scar treatment will reportedly grow at a CAGR of 4.6%. The overall outlook remains moderate yet positive.
Multiple affirmative factors to drive atrophic scar treatment market growth
While soaring demand for atrophic scar treatment and evolving regulatory landscape in developed as well as developing economies are identified to predominantly fuel the market growth within the assessment period, the report also throws light on a range of other prominent drivers responsible for steady growth of the global atrophic scar treatment market.
Topical scar treatment to remain most preferred type during the period of study
Based on product type, the global market for atrophic scar treatment is segmented into topical scar products, laser products, surface treatment, and injectable products. Among these four, topical scar product segment will continue to dominate with over 50% value share despite a slight decline in the market share by 2025 end. Laser segment is expected to witness a declined market share by value but laser therapy is emerging as a popular treatment among affluent consumers. Surface treatment is likely to capture over 20% share of the total market value by 2025 end, followed by injectables. An important observation by Persistence Market Research indicates that topical treatments are gradually losing popularity among wealthy consumer pockets, whereas lasers and injectables are gaining evidently higher traction. However, expensive pricing of the latter two are still a major constraint that will persist throughout the forecast period.
Latin America to emerge most lucrative regional market
Among the various regional markets, North America is foreseen to remain dominant, possibly reaching revenue beyond US$ 2.6 Bn by 2025 end. APAC is identified to be the second largest regional market for atrophic scar treatment, closely trailed by Europe. China, India, and Japan will be the key regions within the Asian Pacific rim. While MEA seems to be a stably growing market, Latin America is expected to witness the fastest growth over the forecast period. According to Persistence Market Research, the market in Latin America will be most lucrative for leading players, led by Brazil due to growing popularity of cosmetic interventions.